PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: deSciner Business Network Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

deSciner Integrates Powerful Search Engine for the Life Sciences from Transinsight into OBBeC Portal - deSciner™ Business Network, the global B2B publishing and communications firm serving specialist scientific markets worldwide, has entered into an agreement with Transinsight to integrate its GoPubMed search engine into deSciner™ OBBeC® Portal
deSciner Integrates Powerful Search Engine for the Life Sciences from Transinsight into OBBeC Portal

 

NewswireToday - /newswire/ - Leicester, Leicestershire, United Kingdom, 2007/06/20 - deSciner™ Business Network, the global B2B publishing and communications firm serving specialist scientific markets worldwide, has entered into an agreement with Transinsight to integrate its GoPubMed search engine into deSciner™ OBBeC® Portal.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Developed by Transinsight in collaboration with the Technical University of Dresden, GoPubMed is an ontology-based search engine for the life sciences, with a ground-breaking new technology which leads to better and faster search results, for both complex and simple queries. In contrast to classical search engines, GoPubMed can answer questions using its background knowledge and can be configured for molecular biology, medicine, drug development, and food science. It can search literature repositories, web sites, third-party intranet and users’ desktops.

“We are extremely delighted to be working closely with Transinsight to integrate such a powerful search engine into OBBeC® Portal,” said Timoor El-Sheikh, Managing Director and CEO of deSciner™ Business Network. “We always strive to bring together advanced content search facilities into OBBeC® Portal (obbec.com), as well as other tools, to enhance our user experience in accessing vital information, news and reference material in relation to life sciences, technology and healthcare, all through a single online interface.”

About deSciner™ Business Network

deSciner™ Business Network (desciner.com) is an international knowledge-base and consultancy company delivering impartial and vendor-neutral media products, web sites and publications to specialist science and business sectors.

About Transinsight

Transinsight (transinsight.com) is a German based company providing solutions for knowledge based search. The award winning company works in close collaboration with the bioinformatics group of the Technical University Dresden. Transinsight and the bioinformatics group are co-located in a technology breeding building hosting groups dedicated to genomics, proteomics, biophysics, tissue engineering, cellular machines and bioinformatics.

Transinsight brings leading edge research to the global market. GoPubMed is the publicly available flagship product which for the first time shows the use of knowledge at an industry standard level.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: deSciner Business Network Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


deSciner Integrates Powerful Search Engine for the Life Sciences from Transinsight into OBBeC Portal

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Marie Deleuil - deSciner.com 
+44(0)11 6250 6063 enquiries[.]desciner.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any deSciner Business Network Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From deSciner Business Network Ltd / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics
Sartorius Announces Expansion of Sartorius Stedim Cellca
Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  BizJobs.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)